Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News |  Now Available: Kuwait Pharmaceuticals & Healthcare Report Q3 2012New Healthcare market report from Business Monitor International: "Kuwait Pharmaceuticals & Healthcare Report Q3 2012"
By: Fast Market Research, Inc. Headline Expenditure Projections * Pharmaceuticals: * Healthcare: KWD1.04bn (US$3.76bn) in 2011 to KWD1.11bn (US$3.98bn) in 2012; +7.3% in local currency terms and +5.9% in US dollar terms. Forecast and historic data down from Q212 owing to new data from the World Healthcare Organization (WHO). * Medical devices: KWD75mn (US$273mn) in 2011 to KWD82mn (US$292mn) in 2012; +7.2% in local currency terms and +5.8% in US dollar terms. Forecast down from Q212. ------------------------------------------------------------ Full Report Details at - http://www.fastmr.com/ ------------------------------------------------------------ Risk/Reward Rating: In BMI's Pharmaceuticals Risk/Reward Ratings (RRRs) table for Q312, Kuwait has fallen back to second position. Its risks profile is stronger than its rewards, which are squeezed by the small market size and political instability that may stall the reform of its healthcare system. Although we don't expect Kuwait to overtake the UAE again in the coming quarters, it will maintain a high position, reflective of the country's high per-capita drug spend and urbanised country structure, which together offset the disadvantages that stem from the small overall size of the pharmaceutical sector. Key Trends And Developments * In February 2012, as part of a drive to improve healthcare for diabetes patients, Kuwait's healthcare service announced that it is partnering with a UK-based health trust to learn how to implement an electronic patient records system. Like Kuwait, the Tayside area of Scotland has a high prevalence of diabetes, making the authority suited to passing on lessons in diabetic patient management. * In May 2012, local news sources in Kuwait reported that drug prices in the country remain prohibitively high and vary between retail outlets. There have been calls for the government to implement more price screening measures to ensure retail outlets are sticking to agreed pricing levels. Controller of the national assembly, Mohammad al-Duwailah, has called for greater vigilance in monitoring the prices of medicines. * The health ministry announced in May 2012 that it would approve a new mechanism to control the cost of medical services in private hospitals and clinics through the Medical Licensing Division so as to protect patients who visit such medical centres. The need for such a system has arisen as patients have complained about prohibitively high healthcare prices. This healthcare inflation can be seen in Kuwait's consumer price inflation (CPI) basket as the cost of hospital services has increased by more than 160% since 2000 when the index was created BMI Economic View: We expect the Kuwaiti economy to continue growing robustly in 2012. Elevated global hydrocarbon prices will allow the government to keep fiscal spending high, driving domestic consumption, while oil production looks set to remain near capacity in the months ahead. While our outlook on fixed investment is less positive, we forecast real GDP growth of 4.5% in 2012, down only modestly on estimated growth of 5.7% last year. BMI Political View: The failure of negotiations between the Kuwaiti emir and opposition MPs for the latter to participate in the new cabinet will weigh on the country's near-term political outlook. Further delays to the implementation of the government's spending plans now appear likely. As a result, we have revised down our short-term political risk rating, as well as a number of our economic forecasts for 2012. Partial Table of Contents: SWOT Analysis - Kuwait Pharmaceuticals And Healthcare Industry SWOT - Kuwait Political SWOT - Kuwait Economic SWOT - Kuwait Business Environment SWOT Pharmaceutical Risk/Reward Ratings - Table: Middle East And Africa Pharmaceutical Risk/Reward Ratings, Q312 - Rewards - Risks Kuwait - Market Summary Regulatory Regime - Foreign Direct Investment Regulations - Intellectual Property Regime - IP Shortcomings - Pricing Regime - Reimbursement Regime - Public Procurement Of Medicines - Regional Harmonisation - Free Trade Agreements Industry Developments - Epidemiology - Communicable Diseases - Non-Communicable Diseases - Healthcare Sector - Healthcare Sector Reform - Healthcare Staff - Primary Care - Secondary Care - Public Health Developments - Healthcare Financing - Healthcare Insurance - Healthcare Insurance Developments - Research & Development - Biotechnology Sector - Clinical Trials - Medical Devices - Table: New Products Launched In 2009 Industry Forecast Scenario - Overall Market Forecast - Table: Pharmaceutical Sales Indicators 2008-2016 - Key Growth Factors - Industry - Table: Healthcare Expenditure Indicators 2008-2016 - Table: Healthcare Governmental Indicators 2008-2016 - Table: Healthcare Private Indicators 2008-2016 - Macroeconomic Forecast - Table: Kuwait Economic Activity, 2011-2016 - Prescription Drug Market Forecast - Table: Prescription Drug Sales Indicators 2008-2016 - Patented Drug Market Forecast - Table: Patented Drug Market Indicators 2008-2016 - Generic Drug Market Forecast - Table: Generic Drug Sales Indicators 2008-2016 - OTC Medicine Market Forecast - Table: OTC Medicine Sales Indicators 2008-2016 - Pharmaceutical Trade Forecast - Table: Exports And Imports Indicators 2008-2016 - Medical Device Market Forecast - Table: Medical Devices Sales Indicators 2008-2016 - Other Healthcare Data - Key Risks To BMI Forecasts Competitive Landscape - Pharmaceutical Industry - Regional Pharmaceutical Sector Developments - Foreign Company Developments - Pharmaceutical Distribution Company Profiles - Local Companies - Full Table of Contents is available at: -- http://www.fastmr.com/ About Business Monitor International Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets. BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports. End
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number